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REUVEN K. SNYDERMAN 
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Recently interest has arisen in 
the topical use of chemotherapeu-
tic agents for the treatment of skin 
cancers and keratoses. Dr. Edmund 
Klein and his group at the Ros-
well Park Memorial Institute in 
Buffalo, New York, carried out 
extensive work in the study of the 
following drugs: Actinomycin D, 
Methotrexate, Spiramycin, Nitro-
gen Mustard, 5-Mercaptouracil, 
Dimethylurethimine and 5-Fluorou-
racil in an acid mantle cream. The 
results showed that many of these 
chemotherapeutic agents were able 
to attack the altered cell of kerato-
sis and skin cancer and produce 
a destruction of the lesion. 
The results showed that 20 % 
5-Fluorouracil in an acid mantle 
cream proved to be the most effec-
tive agent in the treatment of solar 
keratoses and skin cancer. 
Preparation of Ointment 
The 20% 5-Fluorouracil oint-
ment is prepared as follows: The 
5-Fluorouracil crystalline powder 
is micronized in a high speed 
grinder and sieved through a # 100 
mesh screen so that the particles 
are less than 150,u. in size. The 
powder is then intimately levigated 
with a small amount of base using 
a triple roller ointment mill. 
This is then diluted to the de-
sired concentration of 20% and is 
then mixed for at least one hour 
using a large Hobart mixer. The 
vehicle is Acid Mantle Creme of 
Dome Laboratories. 
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Protocol 
Over two years ago a protocol 
was set up in Memorial Sloan-
Kettering Cancer Center to study 
the effect of 20% 5-Fluorouracil 
in an acid mantle cream base in 
the treatment of patients with 
keratoses and skin cancers. 
The patients who have been 
treated have had the disease for 
from 5 to 30 years, and all have 
had the usual modalities of treat-
ment-surgery, x-ray, dessication 
and scraping. They frequently are 
able themselves to detect new 
lesions before their own physician 
finds them, and they are willing to 
try any form of treatment which 
can hold out some promise to 
them. 
Each new patient had the nature 
of the disease and the form of 
treatment carefully discussed with 
him. As the drug is Federal Drug 
Administration controlled, he was 
asked to sign a release which stated 
that he realized this was an investi-
gative project. If possible, a biopsy 
was obtained, or the biopsy report 
from his referring doctor was ac-
cepted. The area to be treated was 
photographed. The patient was in-
structed to apply the ointment 
twice a day and to wash it off 
gently before reapplying it. How-
ever, this was only possible during 
the early stages of the treatment. 
Treatment 
When the patient presented him-
self with an entire face covered 
with keratoses and skin cancers, 
the usual anatomical sections of 
the face, such as the forehead, 
half the face, the nose, etc., were 
treated separately. 
The usual sequence of treat-
ment is as follows: By the fourth 
to seventh day, an area of ery-
thema appears. This occurs not 
only around those areas which were 
clinically suspicious, but also in 
other areas which the examiner 
may not have noted. It is thus be-
lieved that the drug has an af-
finity to find and attack the altered 
cell. From the seventh to 21st days 
the erythema increases. There will 
be some superficial ulceration, and 
crusting will start. Treatment is 
continued to 30 days. When areas 
of the face are being treated, they 
are left open to the air. In areas 
normally covered by clothes, a sim-
ple 4" X 4" dressing with paper 
tape is applied. When occlusive 
dressing is used, the reaction is 
much more marked. At the end of 
30 days, treatment is discontinued. 
The crust is allowed to separate, 
and a pink surface remains which 
is quite similar to that produced by 
superficial abrasion. 
There have been no systemic 
complications whatsoever. Blood 
counts which were studied in the 
early cases showed no alteration. 
The patients have complained of 
pain and a burning sensation. The 
simultaneous application of 20% 
Cortisone preparation has lessened 
this problem. Occasionally there 
will be marked edema around the 
eyes, which can be controlled by 
antihistamines. The most difficult 
problem is the appearance of the 
patient. Those who have a severe 
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facial reaction, especially men, 
whose beards tend to grow through 
the crust, will look frightful. How-
ever, the patient's weekly visit 
serves as a time to reassure him. 
Upon completion of one area, a 
period of time is allowed for eval-
uation. Then, usually, with the pa-
tient freely giving his opinion, we 
are able to determine whether he 
chooses to go on and have another 
area treated. It is to be noted that 
the skin, after treatment, is softer, 
and many fine lines also disappear. 
This is rather encouraging to the 
women patients, but this is only 
temporary edema, and with time 
the fine lines again return. Most 
of the patients who need further 
treatment are anxious to go on, as 
they were pleased with the results. 
When a second course of treat-
ment is given, the response is 
quicker and more severe. The ery-
thema will be produced by the 
second and third day, and ulcera-
tion and crusting will start by the 
seventh to tenth day. The patient 
has probably been made sensitive 
to the drug by the first treatment, 
and the second treatment elicits a 
much quicker response. In the 
future we will be able to take ad-
vantage of this reaction by reduc-
ing the length of time of the treat-
ment or, possibly, by reducing the 
concentration of the ointment. In 
those cases which we have now 
given a third course of treatment, 
the reaction is even more acceler-
ated. The ointment has an affinity 
for the altered cell and does not 
attack normal skin. When placed 
over an entire area, such as the 
forehead, the appearance is one of 
mottling with areas of erythema, 
and normal skin remains untouched 
in between. 
We have advised the patients to 
keep the ointment away from the 
mucous membranes of the eyes, 
mouth, and nose. However, I know 
that on a number of occasions the 
patients have gotten the ointment 
on the various mucous membrane 
surfaces, and there has been no 
untoward reaction. We do not feel 
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that the ointment should be used 
over bare cartilage or bone. 
In the beginning we were hesi-
tant in using 5-FU in the treat-
ment of radiation dermatitis and 
radiation-induced cancer. To date 
we have treated three patients with 
the disease and find a remarkably 
good response. 
Resu lts 
In over 100 cases now treated 
at Memorial Sloan-Kettering Can-
cer Center, the response has been 
excellent. However, these are pa-
tients who for many years have 
developed new lesions. The oint-
ment is only able to remove kera-
toses and basal cell carcinomas 
which are present. It does not alter 
the fundamental makeup of the 
skin, and it must be expected that 
the patient will go on and develop 
new lesions. However, the patients 
who have undergone the treatment 
are extremely grateful for being 
freed of their problem for a period 
of time, whether this be a year, or 
two, or longer. The treatment can 
be repeated any time that new 
lesions appear. 
The individual basal cell cancer 
can still best be treated by surgical 
excision. It is when one is pre-
sented with the multicentric basal 
cell problem and where surgery be-
comes an almost impossible task 
that 5-FU becomes a useful tool. 
Sum m ary 
1. 20% 5-Fluorouracil ointment 
in an acid mantle cream base is a 
useful tool for the treatment of 
multiple basal cell carcinomas and 
keratoses. 
2. The method of treatment to 
date is application twice a day for 
a period of 30 days. 
3. A second course of treatment 
can be applied to the same area or 
to other areas. A more severe re-
action occurs with the second and 
third course of treatment. 
4. The treatment removes the 
lesions which are present but in 
no way alters the skin, and those 
disposed to develop new lesions 
will probably continue to do so in 
the future. 
